| Authors: |
Parlow S; CAPITAL (Cardiovascular Percutaneous Intervention Trials) Research Group (S.P., P.D.S., O.A.-R., R.G.J., P.M., L.R., H.F., B.M., J.W., R.M., B.H.), University of Ottawa, Canada.; Division of Cardiology (S.P., P.D.S., O.A.-R., P.M., M.F., R.M., M.L., B.H.), University of Ottawa, Canada., Di Santo P; CAPITAL (Cardiovascular Percutaneous Intervention Trials) Research Group (S.P., P.D.S., O.A.-R., R.G.J., P.M., L.R., H.F., B.M., J.W., R.M., B.H.), University of Ottawa, Canada.; Division of Cardiology (S.P., P.D.S., O.A.-R., P.M., M.F., R.M., M.L., B.H.), University of Ottawa, Canada.; Heart Institute, School of Epidemiology, Public Health and Preventative Medicine (P.D.S., R.G.J., P.M., J.B., G.A.W.), University of Ottawa, Canada.; Division of Critical Care Medicine (P.D.S.), Ottawa Hospital, Canada., Abdel-Razek O; CAPITAL (Cardiovascular Percutaneous Intervention Trials) Research Group (S.P., P.D.S., O.A.-R., R.G.J., P.M., L.R., H.F., B.M., J.W., R.M., B.H.), University of Ottawa, Canada.; Division of Cardiology (S.P., P.D.S., O.A.-R., P.M., M.F., R.M., M.L., B.H.), University of Ottawa, Canada., Jung RG; CAPITAL (Cardiovascular Percutaneous Intervention Trials) Research Group (S.P., P.D.S., O.A.-R., R.G.J., P.M., L.R., H.F., B.M., J.W., R.M., B.H.), University of Ottawa, Canada.; Heart Institute, School of Epidemiology, Public Health and Preventative Medicine (P.D.S., R.G.J., P.M., J.B., G.A.W.), University of Ottawa, Canada.; Division of Internal Medicine (R.G.J.), Ottawa Hospital, Canada., Motazedian P; CAPITAL (Cardiovascular Percutaneous Intervention Trials) Research Group (S.P., P.D.S., O.A.-R., R.G.J., P.M., L.R., H.F., B.M., J.W., R.M., B.H.), University of Ottawa, Canada.; Division of Cardiology (S.P., P.D.S., O.A.-R., P.M., M.F., R.M., M.L., B.H.), University of Ottawa, Canada.; Heart Institute, School of Epidemiology, Public Health and Preventative Medicine (P.D.S., R.G.J., P.M., J.B., G.A.W.), University of Ottawa, Canada., Robinson L; CAPITAL (Cardiovascular Percutaneous Intervention Trials) Research Group (S.P., P.D.S., O.A.-R., R.G.J., P.M., L.R., H.F., B.M., J.W., R.M., B.H.), University of Ottawa, Canada., Feagan H; CAPITAL (Cardiovascular Percutaneous Intervention Trials) Research Group (S.P., P.D.S., O.A.-R., R.G.J., P.M., L.R., H.F., B.M., J.W., R.M., B.H.), University of Ottawa, Canada., Morgan B; CAPITAL (Cardiovascular Percutaneous Intervention Trials) Research Group (S.P., P.D.S., O.A.-R., R.G.J., P.M., L.R., H.F., B.M., J.W., R.M., B.H.), University of Ottawa, Canada., Wade J; CAPITAL (Cardiovascular Percutaneous Intervention Trials) Research Group (S.P., P.D.S., O.A.-R., R.G.J., P.M., L.R., H.F., B.M., J.W., R.M., B.H.), University of Ottawa, Canada., Toeg H; Division of Cardiac Surgery (H.T., T.A.-A., M.R., V.C.), University of Ottawa, Canada., Al-Atassi T; Division of Cardiac Surgery (H.T., T.A.-A., M.R., V.C.), University of Ottawa, Canada., Ruel M; Division of Cardiac Surgery (H.T., T.A.-A., M.R., V.C.), University of Ottawa, Canada., Kuhar P; Azumio Inc, Redwood City, CA (P.K.)., Bernick J; Cardiovascular Research Methods Centre (J.B., G.A.W.), University of Ottawa, Canada.; Heart Institute, School of Epidemiology, Public Health and Preventative Medicine (P.D.S., R.G.J., P.M., J.B., G.A.W.), University of Ottawa, Canada., Wells GA; Cardiovascular Research Methods Centre (J.B., G.A.W.), University of Ottawa, Canada.; Heart Institute, School of Epidemiology, Public Health and Preventative Medicine (P.D.S., R.G.J., P.M., J.B., G.A.W.), University of Ottawa, Canada., Simard T; Department of Cardiovascular Diseases, Mayo Clinic School of Medicine, Rochester, MN (T.S.)., Marbach JA; Division of Cardiology, Knight Cardiovascular Institute, Oregon Health & Sciences University, Portland (J.A.M.)., Froeschl M; Division of Cardiology (S.P., P.D.S., O.A.-R., P.M., M.F., R.M., M.L., B.H.), University of Ottawa, Canada., Mathew R; CAPITAL (Cardiovascular Percutaneous Intervention Trials) Research Group (S.P., P.D.S., O.A.-R., R.G.J., P.M., L.R., H.F., B.M., J.W., R.M., B.H.), University of Ottawa, Canada.; Division of Cardiology (S.P., P.D.S., O.A.-R., P.M., M.F., R.M., M.L., B.H.), University of Ottawa, Canada., Labinaz M; Division of Cardiology (S.P., P.D.S., O.A.-R., P.M., M.F., R.M., M.L., B.H.), University of Ottawa, Canada., Chan V; Division of Cardiac Surgery (H.T., T.A.-A., M.R., V.C.), University of Ottawa, Canada., Hibbert B; CAPITAL (Cardiovascular Percutaneous Intervention Trials) Research Group (S.P., P.D.S., O.A.-R., R.G.J., P.M., L.R., H.F., B.M., J.W., R.M., B.H.), University of Ottawa, Canada.; Division of Cardiology (S.P., P.D.S., O.A.-R., P.M., M.F., R.M., M.L., B.H.), University of Ottawa, Canada. |
